| 基金名称 | 泰康弘实3个月定期开放混合型发起式证券投资基金 | | --- | --- | | 基金简称 | 泰康弘实 3月定开混合 | | 基金主代码 | 006111 | | 基金管理人名称 | 泰康基金管理有限公司 | | 公告依据 | 《中华人民共和国证券投资基金法》、《公开募集证券投资基金信息 披露管理办法》等相关法律法规以及《泰康弘实 3个月定期开放混 | | | 合型发起式证券投资基金基金合同》、《泰康弘实 3个月定期开放混 | | | 合型发起式证券投资基金招募说明书》 | | 基金经理变更类型 | 解聘基金经理 | | 共同管理本基金的其他经 | 陆建巍、范子铭 | | 理姓名 | | | 离任基金经理姓名 | 桂跃强 | 桂跃强2015年8月加入泰康公募，担任公募事业部权益投资负责人，现任泰康基金权益投资部负责人、 股票基金经理。曾任石油化工科学研究院工程师，新华基金管理有限公司基金管理部副总监、基金经理 等职务。 泰康弘实3月定开混合成立于2018年8月23日，截至2025年12月31日，其2025年收益率为24.00%，成立 来收益率为81.59%，累计净值为1.8056。 中国 ...

2025年12月份收益率表现 从此前公布的最新季报看，宝盈医疗健康沪港深股票在去年三季度前十大重仓股为信达生物、科伦 博泰生物、百利天恒、三生制药、诺诚健华、百济神州、恒瑞医药、康方生物、信立泰、康弘药业。宝 盈创新医疗混合发起式的前十大重仓股为百利天恒、科伦博泰生物、信达生物、三生制药、康方生物、 诺诚健华、康弘药业、信立泰、石药集团、一品红。 对比来看，不仅其中有八只重仓股都相同，而且多只个股都在去年12月里遭遇了大幅下跌，如第一 大重仓股信达生物在当月下跌18.97%，三生制药更是下跌超过22%。 | 名称 | | 复权单位净值增长率% 累计单位净值元 规模 亿元 基金经理 | | | | --- | --- | --- | --- | --- | | 宝盈创新医疗混合发起式C | -14.19 | 0. 8857 | 0. 51 | 姚艺 | | 宝盈创新医疗混合发起式A | -14.14 | 0. 8886 | 0. 47 | 姚艺 | | 宝盈医疗健康沪港深股票C | -13.26 | 1.8650 | 8.29 | 姚艺 | | 宝盈医疗健康沪港深股票A | -13.20 | 1.9630 | ...

Core Viewpoint - In December 2025, 15 funds managed by GF Fund experienced a decline of over 8%, with the GF Healthcare Mixed Fund A and C managed by Wu Xingwu leading the losses at -13.3% and -13.27% respectively [1][2]. Fund Performance Summary - The GF Healthcare Mixed Fund A and C have recorded a decline of 41.19% and 42.41% respectively since their inception on October 21, 2020 [1]. - The top ten holdings of the GF Healthcare Mixed Fund include companies such as Kelun-Botai Biotech, Innovent Biologics, and WuXi AppTec [1]. - Other funds managed by Wu Xingwu, including GF Hong Kong-Shenzhen Healthcare Mixed Fund A and C, also reported significant declines in December [2][3]. Additional Fund Details - The GF Healthcare Mixed Fund A had a unit net value of 0.5881 as of January 5, 2026, with a one-month decline of -6.59% and a one-year return of 38.28% [2]. - The GF Healthcare Mixed Fund C had a unit net value of 0.5759 as of January 5, 2026, with a one-month decline of -6.62% and a one-year return of 37.74% [2]. - Other funds with notable declines include the GF Medical Innovation Mixed Fund A and C, which fell by -12.79% and -12.75% respectively [3][4].

Group 1 - The establishment of the Zhejiang University-Kandi Intelligent Robot Joint R&D Center marks a significant step in the deep integration of artificial intelligence and security inspection robots, initiating an innovative ecological practice of "technology supply - scene implementation - global promotion" [1] - The center will focus on joint research around core technologies of "intelligent perception" and "spatial computing" for quadruped robots, aiming to create an intelligent system that integrates image recognition, behavior analysis, and spatial modeling for automatic detection and response to personnel, objects, and abnormal behaviors in complex industrial scenarios [1] - Zhejiang University emphasizes the importance of this collaboration with Kandi Technology, which is expected to positively impact the implementation of innovation-driven development strategies and promote the transformation of technological achievements in the intelligent security industry [1] Group 2 - Kandi Technology is transitioning from a traditional manufacturing enterprise to a technology innovation-driven platform, with the joint R&D center being a key initiative to enhance its technological attributes and expand into high-value-added intelligent equipment markets [2] - The company is accelerating the diversified application of quadruped robots in security inspection scenarios through an innovative model of "Chinese technology + overseas scenarios + overseas channels," further deepening its global layout [2] - The R&D center will adopt an "end-edge-cloud" collaborative architecture, where quadruped robots serve as front-end perception terminals, edge computing nodes focus on local real-time analysis and rapid response, and cloud-based large models conduct global data analysis, strategy optimization, and task scheduling [2]

隔夜，WTI原油期货2月合约收涨1.74%，报58.32美元/桶。 (责任编辑：张海蛟) 中国经济网北京1月6日讯 今日，上海国际能源交易中心日间盘原油期货主力合约震荡收高，成交放 大，持仓减少。主力2602合约收报428.2元，涨0.33%或1.4元;成交量为68944手;持仓为31596手，日盘持 仓减少2660手。 ...

(责任编辑：张海蛟) 隔夜，COMEX黄金期货涨2.71%，报4459.7美元/盎司。 中国经济网北京1月6日讯 今日，上海期货交易所日间盘黄金期货主力合约震荡收高，成交放大，持仓 减少。主力2602合约收报1004.98元，涨1.27%或12.60元;成交量为192487手;持仓为130217手，持仓减少 2306手。 ...

按上一交易日公司收盘价21.84元计算，万泽集团拟减持套现合计约174,720,000元。 中国经济网北京1月6日讯 万泽股份（000534.SZ）昨日晚间披露《关于控股股东减持股份的预披露 公告》。 根据公告，控股股东万泽集团有限公司（以下简称"万泽集团"）计划在公告披露之日起十五个交易 日后的三个月内（即2026年1月27日至2026年4月26日）通过深圳证券交易所证券交易系统的集中竞价交 易或大宗交易方式减持公司股份不超过8,000,000股，即不超过公司当前总股本（剔除公司回购专用证券 账户持股数量）的1.6585%。 截至公告披露日，万泽集团及其一致行动人（万泽集团-红塔证券-23泽EB02担保及信托财产专户、 万泽集团-红塔证券-25泽EB02担保及信托财产专户、万泽集团-红塔证券-25泽EB03担保及信托财产专 户、万泽集团-红塔证券-25泽EB04担保及信托财产专户）目前合计持有公司股份155,860,449股，占公司 当前总股本（剔除公司回购专用证券账户持股数量）的比例为32.3126%。 (责任编辑：魏京婷) 本次减持计划实施不会导致公司控制权发生变更，也不会对公司治理结构及持续经营产生重 ...

Core Viewpoint - The announcement from Nanya New Materials (688519.SH) reveals a share reduction plan involving several shareholders, which is expected to take place over a three-month period starting 15 trading days after the announcement [1][2]. Group 1: Share Reduction Details - A total of 7 shareholders plan to reduce their holdings, with a combined maximum of 2,434,109 shares, representing up to 1.04% of the company's total share capital [1]. - Individual shareholders' planned reductions include: Bao Xiuchun (up to 649,000 shares, 0.28%), Zheng Guangle (up to 387,000 shares, 0.16%), Huang Jianke (up to 312,000 shares, 0.13%), Bao Xiuliang (up to 108,000 shares, 0.05%), Bao Ailan (up to 87,000 shares, 0.04%), Gao Hai (up to 326,109 shares, 0.14%), and Zheng Xiaoyuan (up to 565,000 shares, 0.24%) [1][2]. Group 2: Financial Implications - The total estimated cash from the planned share reductions is approximately 195,580,658.15 yuan, based on the previous trading day's closing price of 80.35 yuan per share [2]. - The actual controllers and directors hold significant shares, with Bao Xiuchun holding 2,597,621 shares (1.11%), Zheng Guangle 1,549,853 shares (0.66%), and others holding smaller percentages [2]. Group 3: Control and Governance - The actual controllers of the company include Bao Xiuyin, Bao Xiuchun, and several others, collectively holding 47.76% of the shares, ensuring that the control of the company remains unchanged despite the planned reductions [3]. - The share reduction is stated to be based on personal financial needs and is not expected to impact the company's governance structure or ongoing operations significantly [3]. Group 4: Previous Fundraising Activities - Nanya New Materials raised a total of 19.10 billion yuan during its initial public offering (IPO) in August 2020, with a net amount of 17.86 billion yuan after deducting issuance costs [6]. - The company plans to raise up to 900 million yuan through a targeted issuance of A-shares, with the net proceeds intended for AI-based high-frequency circuit board development and working capital [7].

Core Viewpoint - The company Guangyun Da (300227.SZ) plans to issue shares to specific investors to raise up to RMB 121,062.98 million, primarily for working capital and repaying bank loans [1][3]. Group 1: Share Issuance Details - The share issuance will consist of domestic listed RMB ordinary shares (A-shares) with a par value of RMB 1.00 per share [1]. - The shares will be issued to Jun Guang Investment, a wholly-owned subsidiary of the company's controlling shareholder, Guangyun Da Group, and the issuance constitutes a related party transaction [2]. - The determined issuance price is RMB 7.25 per share, which is not less than 80% of the average trading price over the 20 trading days prior to the pricing date [1]. Group 2: Historical Context and Comparisons - The number of shares to be issued will not exceed 166,983,417 shares, representing up to 30% of the company's total share capital before the issuance [1]. - The current fundraising amount significantly exceeds the amounts proposed in previous years, with the 2025 plan aiming for RMB 37,178.00 million and the 2024 plan for RMB 44,892.00 million [3]. - The company has previously conducted non-public offerings in 2019 and 2020, raising a total of approximately RMB 472 million [7]. Group 3: Financial Performance - In 2024, the company reported revenue of RMB 1,118.17 million, a year-on-year increase of 4.23%, but a net loss attributable to shareholders of RMB -27.37 million, compared to a profit of RMB 56.82 million in the previous year [7][8]. - For the first nine months of 2025, the company achieved revenue of RMB 965 million, a 23.13% increase year-on-year, but reported a net loss of RMB -52.44 million [9].

Core Viewpoint - The announcement from Hangya Technology (688510.SH) regarding the share reduction plan by its shareholders indicates a planned reduction of up to 7,165,000 shares, which represents 2.76% of the company's total share capital [1][2]. Group 1: Shareholder Reduction Plans - Director Ruan Shihai plans to reduce his holdings by up to 4,900,000 shares, accounting for 1.89% of the total shares [1]. - Wuxi Huahang Kechuang Investment Center (Limited Partnership) intends to reduce its holdings by up to 2,265,000 shares, representing 0.87% of the total shares [1]. - The total planned reduction by both shareholders amounts to approximately 192,666,850 yuan based on the previous trading day's closing price of 26.89 yuan [2]. Group 2: Shareholding Structure - As of the announcement date, Ruan Shihai holds 16,975,091 shares, which is 6.54% of the total share capital, while Huahang Kechuang holds 8,193,300 shares, or 3.16% [2]. - The shareholders mentioned have a group of concerted actions, including individuals such as Yan Qi and others, collectively holding 76,874,043 shares, which is 29.62% of the total share capital [2]. Group 3: Company Background - Hangya Technology was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on December 16, 2020, with an initial issuance of 64.6 million shares at a price of 8.17 yuan per share [3]. - The total funds raised during the IPO amounted to 528 million yuan, with a net amount of 474 million yuan after deducting issuance costs [3]. - The company initially planned to raise 672 million yuan, with 578 million yuan allocated for expanding production capacity of key components for aircraft engines [3].